We are thrilled to announce that starting from Oct 2019 our company will participate in PAVE, a challenging project that aims to develop novel vaccine approaches, including use of multiple immunomodulating components for treatment of pancreatic cancer.

#vaccine #pancreaticcancer #h2020 #msca #cancertherapy

Click here to learn more about PAVE!